article thumbnail

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.

article thumbnail

Big data offers promise of better groundwater management in California

Scienmag

Analysis of 200,000 groundwater samples reveals major mismatch in California groundwater data To ensure that California’s groundwater is sustainably managed in the future and over the long-term, current state definitions of what constitutes groundwater may need to be revised, according to research published this week in PNAS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: In Theranos’s backyard, a health tech leader takes another crack at better blood tests

STAT News

PALO ALTO — Step outside the quiet Stanford Medicine building where geneticist and prominent big data expert Mike Snyder has spent years poring over tiny samples of blood, and you can just see the outline of 1701 Page Mill Road, one of the original offices of Theranos. Continue to STAT+ to read the full story…

Big Data 119
article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, big data, apps, and personalized medicine. Reena Kolar , Ph.D,

article thumbnail

Rare diseases, repurposing and the role of AI

pharmaphorum

These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. In the quest to repurpose a drug for a rare condition, there is a need to look at any and all available data.

Trials 105
article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, big data, apps, and personalized medicine. Reena Kolar , Ph.D,

article thumbnail

A history of AstraZeneca

pharmaphorum

Meanwhile, the search for the ‘right target’ led the company to collaborate with Cancer Research UK and launch the Functional Genomics Centre , a centre of excellence for genetic screening, cancer modelling and big data processing aimed at accelerating the discovery of new cancer medicines, including those based on CRISPR technology.